Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1985Rinsho yakuri/Japanese Journal of Clinical Pharmacology and TherapeuticsOpen Access

Pharmacokinetics and pharmacodynamics after administration of a single oral dose of aprindine hydrochloride.

View Full Paper
Ask AI
Bookmark
Share

Key result

A single 100 to 150 mg oral dose of aprindine hydrochloride effectively reduced ventricular premature contractions by at least 80% for 2 or more consecutive hours in 58% of patients.

Why the study?

What are the pharmacokinetic properties and clinical effects on ventricular premature contractions of a single oral dose of aprindine hydrochloride?

Population

29 patients with frequent ventricular premature contractions (VPCs)

Design

Cohort

Follow-up

up to 11 hours post-administration for Holter monitoring

Authors

MYMitsuhiro YokotaGeneral / Preventive / LipidsKMKazuaki MiyaharaTokyo Metropolitan Komagome HospitalISIwao SotobataFujita Health University

Discussion

Loading...

Member takes

Implication

May inform acute VPC dosing via plasma levels; hypothesis-generating and requires RCTs before practice change.

Structured PICO

What are the pharmacokinetic properties and clinical effects on ventricular premature contractions of a single oral dose of aprindine hydrochloride?

P
Population
29 patients (mean age 54 years, 41.4% female) with frequent ventricular premature contractions who received a single oral dose of aprindine for pharmacokinetic and pharmacodynamic evaluation.
I
Intervention
Single 100 to 150 mg oral dose of aprindine hydrochloride
O
Outcome
Pharmacokinetic parameters (Cmax, Tmax, T1/2β), clinical effects on VPCs, and minimal effective plasma levelssurrogate

A single oral dose of aprindine hydrochloride effectively reduces frequent ventricular premature contractions with a mean effective time of 7.8 hours and a minimal effective plasma level of 0.38 μg/ml.

Limitations

  • Single-dose study design may not fully reflect steady-state pharmacokinetics during continuous administration.
  • Large inter-individual variation in minimal effective plasma levels.
  • Small sample size.

Cite This Study

Yokota et al. (1985) studied Frequent ventricular premature contractions (VPCs) (n=29). Aprindine hydrochloride vs. Baseline (pre-administration) was evaluated on Proportion of patients with at least an 80% decrease in VPCs per hour for 2 or more consecutive hours. A single 100 to 150 mg oral dose of aprindine hydrochloride effectively reduced ventricular premature contractions by at least 80% for 2 or more consecutive hours in 58% of patients.

synapsesocial.com/papers/6a205cd7e6386eb04298f7b2https://doi.org/10.3999/jscpt.16.417
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intracellular electrophysiological alterations in canine cardiac conducting tissue induced by aprindine and lignocaine1976 · 43 citations
  2. 2Mitral-Valve Prolapse Syndrome and Recurrent Ventricular Tachyarrhythmias1978 · 80 citations
  3. 3Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy.1978 · 257 citations